Search results for "Status"

showing 10 items of 2571 documents

Non small cell lung cancer patients with ECOG PS2: unsolved questions and lessons from clinical trials

2005

In the last two decades the results of medical treatment of advanced non-small cell lung cancer (NSCLC) have constantly improved even if they are still far from being considered satisfactory. Today systemic cisplatin-based chemotherapy (CT) is able to increase survival and improve cancer-related symptoms in patients with advanced ‘wet’ stage III and metastatic stage IV NSCLC, but it not clear if the benefits of CT also apply to patients with poor performance status (PS) [1, 2]. PS is the most powerful independent prognostic factor in advanced NSCLC since it is a reliable measure of functional independence, ability to perform daily activities and work, and a strong predictor of survival and …

Oncologymedicine.medical_specialtyLung Neoplasmsbusiness.industryDrugs Investigationallung cancer performance status 2 chemotherapy best supportive careHematologymedicine.diseaseClinical trialRegimenOncologyQuality of lifeCarcinoma Non-Small-Cell LungInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansControlled Clinical Trials as TopicStage (cooking)Lung cancerbusinessAdverse effectSurvival rateSurvival analysisNeoplasm StagingAnnals of Oncology
researchProduct

Does an optimal therapeutic sequence exist in advanced non-small cell lung cancer?

2008

A growing percentage of patients affected by advanced non-small cell lung cancer who progressed after first-line chemotherapy still have a good performance status and require second-line treatment.An overview of the state of the art of second-line therapeutic options is presented.The scope of the review is to give an update on the therapeutic options currently available for the second-line treatment of patients with advanced non-small cell lung cancer.Among chemotherapeutic drugs docetaxel and pemetrexed have been approved for second-line treatment of advanced non-small cell lung cancer. Although the drugs are equiactive in terms of response rate and survival parameters the latter has a cle…

Oncologymedicine.medical_specialtyLung Neoplasmsmedicine.medical_treatmentAntineoplastic AgentsCarcinoma Non-Small-Cell LungInternal medicinemedicineHumansPharmacology (medical)Lung cancerSalvage TherapyPharmacologyResponse rate (survey)Clinical Trials as TopicChemotherapyPerformance statusbusiness.industryDecision TreesGeneral Medicinemedicine.diseaseTreatment OutcomePemetrexedDocetaxelTolerabilityQuality of LifeErlotinibbusinessmedicine.drugExpert Opinion on Pharmacotherapy
researchProduct

The Role of Religiosity in Symptom Expression of Advanced Cancer Patients

2021

Aim: The aim of this study was to assess the religious pattern and its impact on symptom expression in patients with advanced cancer. Methods: A consecutive sample of advanced cancer patients screened at admission to palliative care. Standard epidemiological data were recorded. Patients were asked about their religious beliefs, the degree of social relationship to existing religions, the role of religion in their life, and the frequency of their prayer. The Edmonton Symptom Assessment Scale (ESAS) and Hospital Anxiety Depression scale (HADS) were assessed. Results: Two-hundred-eighty-three patients were screened. Age and gender were found to be independently correlated with religious belief…

Oncologymedicine.medical_specialtyPalliative careCONSECUTIVE SAMPLEReligiosityreligiosity.NeoplasmsInternal medicinemedicineHumansadvanced cancerIn patientKarnofsky Performance StatusAgedpalliative carebusiness.industryGeneral MedicineanxietyAdvanced cancerreligiosityReligionExpression (architecture)AnxietyFemaleSymptom Assessmentmedicine.symptombusiness
researchProduct

Response to the letter to the Editor: Comments on marital status is a prognostic factor in amyotrophic lateral sclerosis. Safiri S et al

2018

Oncologymedicine.medical_specialtyPrognostic factorLetter to the editorPrognosibusiness.industryAmyotrophic Lateral SclerosisMEDLINEMarital StatuGeneral Medicinemedicine.disease03 medical and health sciences0302 clinical medicineNeurologyInternal medicinemedicineMarital status030212 general & internal medicineNeurology (clinical)Amyotrophic lateral sclerosisbusiness030217 neurology & neurosurgeryHumanActa Neurologica Scandinavica
researchProduct

The role of second and third line tyrosine kinase inhibitor monotherapy in EGFR wild-type (and unknown mutational status) advanced non-small-cell lun…

2015

Oncologymedicine.medical_specialtybusiness.industrymedicine.drug_classWild typeHematologymedicine.diseaseTyrosine-kinase inhibitorOncologyThird lineInternal medicinemedicineRetrospective analysisMutational statusNon small cellbusinessLung cancerAnnals of Oncology
researchProduct

Mosaic Study: Actualization of Overall Survival (Os) with 10 Years Follow Up and Evaluation of Braf. By Gercor and Mosaic Investigators

2014

ABSTRACT Aim: The MOSAIC study (Andre T, N Engl J Med, 2004) has demonstrated in patients with stage II/III resected colon cancer (CC) a benefit of oxaliplatin added to 5FU and LV (LV5FU) in 3-year disease-free survival (DFS) and in overal survival (OS). LV5FU and oxaliplatin (FOLFOX4) has also shown a benefit in deficient MisMatch Repair (dMMR) CC pts (Flejou JF, J Clin Oncol 31: 2013;suppl; abstr 3524). We report here 1) Results of MOSAIC after 10 year follow-up, and 2) results in the BRAF evaluable population. Methods: Of the 2246 patients included in the MOSAIC study (whole population), the actualization of survival data was done with 10 yrs follow up. Formalin-fixed, paraffin-embedded …

Oncologymedicine.medical_specialtyeducation.field_of_studyMultivariate analysisbusiness.industryColorectal cancerPopulationHematologymedicine.diseaseOxaliplatinSurgeryOncologyInternal medicinemedicineAdjuvant therapyOverall survivalMutational statusStage (cooking)businesseducationneoplasmsmedicine.drugAnnals of Oncology
researchProduct

Current questions for the treatment of advanced gastric cancer.

2013

Abstract Background Gastric cancer remains a major health problem worldwide. Treatment of advanced gastric cancer is controversial and there is no standard regimen for first- or second-line chemotherapy (CT). This review aims to give an overview of the hot topics concerning treatment, prognostic factors and new strategies in advanced gastric cancer. Material and methods Seven questions of special clinical interest have been formulated previously to the literature review. With the aim of answering each of these questions, a specific search of the relevant trials and meta-analyses published or communicated from 1990 to date was performed. Results Patients treated with CT have a survival benef…

Oncologymedicine.medical_specialtymedicine.medical_treatmentAntibodies Monoclonal HumanizedTargeted therapyTrastuzumabStomach NeoplasmsInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansRadiology Nuclear Medicine and imagingMolecular Targeted TherapyRandomized Controlled Trials as TopicPerformance statusbusiness.industryCancerGeneral MedicineTrastuzumabmedicine.diseaseSurgeryOxaliplatinIrinotecanRegimenOncologyDocetaxelbusinessmedicine.drugCancer treatment reviews
researchProduct

Perioperative Chemotherapy in Poorly Differentiated Neuroendocrine Neoplasia of the Bladder: A Multicenter Analysis

2020

There is scant evidence about optimal management of poorly differentiated neuroendocrine carcinoma of the bladder (BNEC). We performed a multicenter retrospective study on BNEC patients from 13 Italian neuroendocrine-dedicated centers to analyze strategies associated with better outcomes. Mixed adeno-neuroendocrine carcinomas (MANEC) were included. We analyzed overall survival (OS) in the overall cohort, relapse-free survival (RFS) in radically operated patients and progression-free survival (PFS) in patients who received chemotherapy for metastatic disease. Fifty-one BNEC patients were included (male: 46, median age: 70 years). Overall, median OS was 16.0 months, radical tumor resection wa…

Oncologymedicine.medical_specialtymedicine.medical_treatmentNeuroendocrine Carcinoma (NEC)030232 urology & nephrologylcsh:MedicineDiseaseSmall-cell carcinomaArticle03 medical and health sciences0302 clinical medicineInternal medicineMedicinedisease-specific survivalStage (cooking)prognostic factorbladdersmall cell carcinomaChemotherapyPerformance statusbusiness.industryPoorly differentiatedlcsh:Rprognostic factorsRetrospective cohort studyGeneral Medicinemedicine.diseaseperioperative chemotherapy030220 oncology & carcinogenesisCohortbusinessbladder; disease-specific survival; neuroendocrine carcinoma (nec); perioperative chemotherapy; prognostic factors; small cell carcinomaJournal of Clinical Medicine
researchProduct

Company matters: Goal-related social capital in the transition to working life

2005

Abstract Using longitudinal data on 343 young adults, the present study investigated the social ties involved in young adults’ work-related goals, how these ties change during transition to working life, and whether social ties contribute to success in dealing with the transition. The results showed that goal-relevant social ties reflected changes in the young adults’ developmental context. Furthermore, social ties that included a person with high socioeconomic status and weaker social ties contributed to employment success, whereas social ties containing one’s supervisor were associated with quality of employment. The results also showed that goal-related social hindrance increased young a…

Organizational Behavior and Human Resource ManagementAdult developmentContext (language use)EducationSocial supportInterpersonal tiesJob satisfactionLife-span and Life-course StudiesPsychologySocial psychologySocioeconomic statusSchool-to-work transitionApplied PsychologySocial capitalJournal of Vocational Behavior
researchProduct

Shaking the Status Quo: Business Accreditation and Positional Competition

2018

Modern business schools exist in a complex world of rankings, ratings, and credentials. Some argue that in increasingly competitive global higher education markets, signaling status and quality has actually become more important than having them (Gioia & Corley, 2002; Trank & Rynes, 2003). For many contemporary business schools, international accreditations have become key means and first steps in pursuing legitimacy and global status. In this essay, we elaborate in detail on a business school’s international accreditation process, including its motivations and outcomes. We conclude that while accreditation processes are, at best, fruitful quality improvement exercises, the inherent motivat…

Organizational Behavior and Human Resource Managementschools of economics and business administrationHigher educationStatus quomedia_common.quotation_subjectAccountingaccreditationEducationCompetition (economics)kilpailu (talous)0502 economics and businessComputingMilieux_COMPUTERSANDEDUCATIONquality systemsta516Quality (business)ta512media_commonAccreditationkauppakorkeakoulutlaatujärjestelmätbusiness.industry05 social sciences050301 educationGeneral Medicinekilpailu (toiminta)akkreditointibusiness0503 educationcompetition (economics)050203 business & managementAcademy of Management Learning & Education
researchProduct